Previous 10 | Next 10 |
Milestone Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference Canada NewsWire MONTREAL and CHARLOTTE, N.C., Nov. 11, 2020 MONTREAL and CHARLOTTE, N.C., Nov. 11, 2020 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq:...
Gainers: Cassava Sciences (SAVA) +13%, Medigus (MDGS) +10%, STRATA Skin Sciences (SSKN) +9%, CASI Pharmaceuticals (CASI) +8%, BOQI International Medical (BIMI) +7%.Losers: Neovasc (NVCN) -14%, ProPhase Labs (PRPH) -14%, Mileston...
KBS Fashion Group (KBSF) -20%.Puhui Wealth Investment Management (PHCF) -19%.Milestone Pharmaceuticals (MIST) -19% after pricing $45M equity offering.Limelight Networks (LLNW) -18% downgraded at Craig-Hallum after profit miss, margin weakness.Neovasc (NVCN) -15%.Sigma Labs...
Milestone Pharmaceuticals (MIST) has priced its public offering of ~3.8M common shares and, to certain investors, pre-funded warrants to purchase ~4.8M common shares at $0.01 at $5.25 per share of stock and $5.24 per warrant. Gross proceeds should be $45M.Underwriters' over-allotment is an ad...
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants Canada NewsWire MONTREAL and CHARLOTTE, N.C., Oct. 23, 2020 MONTREAL and CHARLOTTE, N.C. , Oct. 23, 2020 /CNW/ -- Milestone Pharmaceut...
Gainers: [[ZDGE]] +41.4%. [[MRIN]] +15.1%. [[CLPS]] +10.8%. [[SAM]] +9.9%. [[MMYT]] +6.4%.Losers: [[USX]] -16.9%. [[CYBE]] -16.4%. [[LLNW]] -15.9%. [[MIST]] -15.8%. [[EHTH]] -11.7%. For further details see: SAM, LLNW, EHTH and MRIN among after-hours movers ...
Milestone Pharmaceuticals (MIST) initiates a public offering of common stock and, to certain investors, pre-funded warrants.Prices, volumes and terms have yet to be announced.Shares down 2% after hours. For further details see: Milestone Pharmaceuticals launches equity offerin...
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants PR Newswire MONTREAL and CHARLOTTE, N.C., Oct. 22, 2020 MONTREAL and CHARLOTTE, N.C. , Oct. 22, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasd...
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments Canada NewsWire MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST)...
MONTREAL and CHARLOTTE, N.C., Aug. 12, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the secon...
News, Short Squeeze, Breakout and More Instantly...
Milestone Pharmaceuticals Inc. Company Name:
MIST Stock Symbol:
NASDAQ Market:
Milestone Pharmaceuticals Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
MONTREAL and CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will host Part I of its virtual investor educ...
MONTREAL and CHARLOTTE, N.C., May 31, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will participate in the Jefferies Global Healthcare Conference being held in New York City, NY from June 4-6, 2024. ...